EUVIMEDEUVIMED entdecken
Crossref

Characterization of Pleural Mesothelioma by Hierarchical Clustering Analyses Using Immune Cells within Tumor Microenvironment

Shingo Inaguma, Chengbo Wang, Sunao Ito, Akane Ueki, Jerzy Lasota, Piotr Czapiewski, Renata Langfort, Janusz Rys, Joanna Szpor, Piotr Waloszczyk, Krzysztof Okoń, Wojciech Biernat und 4 weitere

Pathobiology · 2024

DOI: 10.1159/000538520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathobiology, 2024. Verfasst von Shingo Inaguma und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Nagoya City University East Medical Center, Nagoya, Japan. Hauptthemen laut MEDLINE: Tumor Microenvironment, Pleural Neoplasms, Lymphocytes, Tumor-Infiltrating, Biomarkers, Tumor. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Over the past decade, classifications using immune cell infiltration have been applied to many types of tumors; however, mesotheliomas have been less frequently evaluated.

Methods

In this study, 60 well-characterized pleural mesotheliomas (PMs) were evaluated immunohistochemically for the characteristics of immune cells within tumor microenvironment (TME) using 10 immunohistochemical markers: CD3, CD4, CD8, CD56, CD68, CD163, FOXP3, CD27, PD-1, and TIM-3. For further characterization of PMs, hierarchical clustering analyses using these 10 markers were performed.

Results

Among the immune cell markers, CD3 (p < 0.0001), CD4 (p = 0.0016), CD8 (p = 0.00094), CD163+ (p = 0.042), and FOXP3+ (p = 0.025) were significantly associated with an unfavorable clinical outcome. Immune checkpoint receptor expressions on tumor-infiltrating lymphocytes such as PD-1 (p = 0.050), CD27 (p = 0.014), and TIM-3 (p = 0.0098) were also associated with unfavorable survival. Hierarchical clustering analyses identified three groups showing specific characteristics and significant associations with patient survival (p = 0.016): the highest number of immune cells (ICHigh); the lowest number of immune cells, especially CD8+ and CD163+ cells (ICLow); and intermediate number of immune cells (ICInt). ICHigh tumors showed significantly higher expression of PD-L1 (p = 0.00038). Cox proportional hazard model identified ICHigh [hazard ratio (HR) = 2.90] and ICInt (HR = 2.97) as potential risk factors compared with ICLow. Tumor CD47 (HR = 2.36), tumor CD70 (HR = 3.04), and tumor PD-L1 (HR = 3.21) expressions were also identified as potential risk factors for PM patients.

Conclusion

Our findings indicate immune checkpoint and/or immune cell-targeting therapies against CD70-CD27 and/or CD47-SIRPA axes may be applied for PM patients in combination with PD-L1-PD-1 targeting therapies in accordance with their tumor immune microenvironment characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentPleural NeoplasmsLymphocytes, Tumor-InfiltratingBiomarkers, TumorHumansMaleFemaleMiddle AgedAgedCluster AnalysisMesotheliomaAdultMesothelioma, MalignantAged, 80 and overPrognosisImmunohistochemistry

Stichwörter der Autor:innen

CD47CD70Hierarchical clustering analysisImmune evasionImmunohistochemistryPD-L1 (CD274)Pleural mesothelioma

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Nagoya City University East Medical Center, Nagoya, Japan.
  • Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland, USA.
  • Department of Pathology, Dessau Medical Centre, Dessau-Roßlau, Germany.
  • Department of Pathology, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.

Zitieren

APA

Inaguma, S., Wang, C., Ito, S., Ueki, A., Lasota, J., Czapiewski, P., Langfort, R., Rys, J., Szpor, J., Waloszczyk, P., Okoń, K., Biernat, W., Takiguchi, S., Schrump, D. S., Miettinen, M., & Takahashi, S. (2024). Characterization of Pleural Mesothelioma by Hierarchical Clustering Analyses Using Immune Cells within Tumor Microenvironment. Pathobiology. https://doi.org/10.1159/000538520

Vancouver

Inaguma S, Wang C, Ito S, Ueki A, Lasota J, Czapiewski P, et al. Characterization of Pleural Mesothelioma by Hierarchical Clustering Analyses Using Immune Cells within Tumor Microenvironment. Pathobiology. 2024. doi:10.1159/000538520

BibTeX
@article{Inaguma2024,
  author = {Inaguma, Shingo and Wang, Chengbo and Ito, Sunao and Ueki, Akane and Lasota, Jerzy and Czapiewski, Piotr and Langfort, Renata and Rys, Janusz and Szpor, Joanna and Waloszczyk, Piotr and Okoń, Krzysztof and Biernat, Wojciech and Takiguchi, Shuji and Schrump, David S and Miettinen, Markku and Takahashi, Satoru},
  title = {Characterization of Pleural Mesothelioma by Hierarchical Clustering Analyses Using Immune Cells within Tumor Microenvironment},
  journal = {Pathobiology},
  year = {2024},
  doi = {10.1159/000538520}
}
Kostenlos starten →